# Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

> **NCT01921296** · PHASE2 · TERMINATED · sponsor: **Lynn Henry** · enrollment: 2 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders
- Pain

## Interventions

- **DRUG:** Cyclobenzaprine

## Key facts

- **NCT ID:** NCT01921296
- **Lead sponsor:** Lynn Henry
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2014-05
- **Final completion:** 2015-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Accrual terminated early because of poor accrual
- **Last updated:** 2016-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921296, "Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01921296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*